Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 4Q Financial Reports: Covance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

4Q Financial Reports: Covance

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Covance

4Q Revenues: $343 million (+21%)

4Q Earnings: $30 million (+9%)

FY Revenues: $1.3 billion (+18%)

FY Earnings: $119.6 million (+22%)

Comments: Early development revenues for the quarter grew 24% to $151 million. Full-year revenues grew 17.4% to $562.2 million. Late-stage development revenues for the quarter were $171.4 million, up 16.4% and revenue growth for the year was 16.4% to $631 million. During the year, the company’s backlog increased $210 million, or 14.4%, to a record $1.67 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters